Sea Water Nasal Spray Market Scope and Analysis by 2030
Sea Water Nasal Spray Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 2,446.42 Million |
Market Size by 2030 | US$ 3,812.22 Million |
Global CAGR (2022 - 2030) | 5.7% |
Historical Data | 2020-2022 |
Forecast period | 2022-2030 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Industry Developments and Future Opportunities:
Several initiatives taken by key market players operational in the global sea water nasal spray market are listed below:
- In January 2023, Viatris Inc. announced that it had closed its Oyster Point Pharma and Famy Life Sciences acquisitions to establish a new Viatris Eye Care Division. This acquisition would help the company in its business expansion.
- In March 2023, Teva Pharmaceuticals launched additional strengths of Revlimid (lenalidomide capsules) in 2.5 mg and 20 mg for the generic version in the US. This product launch would help the company expand its product portfolio.
Competitive Landscape and Key Companies:
Sterimar, LABORATOIRE DE LA MER, Gerolymatos International, Humer, Gifrer, GSK, Nacur Healthcare, Laboratoires Pharmaster, Bayer, and Sandoz are among the top 10 players companies in the sea water nasal spray market. These companies focus on presenting new high-tech products, technological advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.